Paper · 33754043
FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells.
Wang J and 20 others. Theranostics, 2021. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Papers, record 33754043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33754043
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Signaling | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Cell Self Renewal | Major topic |
| Fibroblast Growth Factors | Major topic |
| Liver Neoplasms | Major topic |
| NFATC Transcription Factors | Major topic |
| Neoplastic Stem Cells | Major topic |
| Cell Line, Tumor | |
| Humans | |
| MAP Kinase Signaling System | |
| Phospholipase C gamma | |
| Signal Transduction |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,723,449 | Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. | Circ Res | 2008 | https://conductscience.org/library/papers/18723449 | PubMed |
| 2 | 31,114,916 | WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31114916 | PubMed |
| 3 | 22,473,773 | Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. | Hepatology | 2012 | https://conductscience.org/library/papers/22473773 | PubMed |
| 4 | 24,393,342 | Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations. | Liver Int | 2014 | https://conductscience.org/library/papers/24393342 | PubMed |
| 5 | 27,632,571 | FGF2 and EGF Are Required for Self-Renewal and Organoid Formation of Canine Normal and Tumor Breast Stem Cells. | J Cell Biochem | 2017 | https://conductscience.org/library/papers/27632571 | PubMed |
| 6 | 30,085,405 | NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway. | Cancer Med | 2018 | https://conductscience.org/library/papers/30085405 | PubMed |
| 7 | 29,184,418 | FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/29184418 | PubMed |
| 8 | 15,866,891 | STIM1, an essential and conserved component of store-operated Ca2+ channel function. | J Cell Biol | 2005 | https://conductscience.org/library/papers/15866891 | PubMed |
| 9 | 17,361,175 | The molecular choreography of a store-operated calcium channel. | Nature | 2007 | https://conductscience.org/library/papers/17361175 | PubMed |
| 10 | 31,040,921 | NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4. | Oncotarget | 2019 | https://conductscience.org/library/papers/31040921 | PubMed |
1 to 10 of 60
See all 60 referencesCited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,848,145 | Cancer-associated mitochondrial homeostasis disrupted and retrograde signaling activated. | Med Oncol | 2026 | https://conductscience.org/library/papers/42848145 | PubMed |
| 42,633,326 | Advances in FGF/FGFR Signaling: Implications for Disease and Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42633326 | PubMed |
| 42,491,058 | The role of FGF19-FGFR4 signaling pathway in liver health and disease: Guardian or destroyer. | Genes Dis | 2026 | https://conductscience.org/library/papers/42491058 | PubMed |
| 42,463,639 | Dual-faced metabolic reprogramming powers proliferation: FGF21 drives lung squamous carcinoma progression via CaMKII-DRP1-mediated mitochondrial fission. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42463639 | PubMed |
| 42,445,406 | SDF4: a novel prognostic biomarker and therapeutic target in hepatocellular carcinoma revealed by integrated multi‑omics analysis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445406 | PubMed |
| 42,387,364 | Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy. | Animal Model Exp Med | 2026 | https://conductscience.org/library/papers/42387364 | PubMed |
| 41,832,306 | FGF family in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41832306 | PubMed |
| 41,749,109 | Gene expression regulation by Ca2+ signaling: an updated systematic review. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/41749109 | PubMed |
| 41,328,353 | FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities. | Theranostics | 2026 | https://conductscience.org/library/papers/41328353 | PubMed |
| 41,146,849 | Regulation of Histone Acetylation During Inflammation Resolution. | Immunotargets Ther | 2025 | https://conductscience.org/library/papers/41146849 | PubMed |
1 to 10 of 34
See all 34 cited byGenes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| ALDH1A1 | 216 | PubTator's text mining | https://conductscience.org/library/genes/216 | NCBI Gene |
| CALM1 | 801 | PubTator's text mining | https://conductscience.org/library/genes/801 | NCBI Gene |
| CAMK2G | 818 | PubTator's text mining | https://conductscience.org/library/genes/818 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| FGF19 | 9,965 | PubTator's text mining | https://conductscience.org/library/genes/9965 | NCBI Gene |
| FGF2 | 2,247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| FGF4 | 2,249 | PubTator's text mining | https://conductscience.org/library/genes/2249 | NCBI Gene |
1 to 10 of 34
See all 34 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33754043
GET https://conductscience.org/api/papers/v1/33754043/authors?page=2